FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|San Diego beach reopened after hammerhead shark spotted 2 days in row|
|The coast seems to be clear after shark sightings Saturday and Sunday along the San Diego coastline.|
|$20 found in San Francisco leads to $1 million lottery win|
|A San Francisco Bay Area man won $1 million in the California Lottery after buying a winning ticket with money he found at the airport.|
|3 Reasons Why a Latino Family's Tiny Cheese Business Became a Giant|
|Not all family businesses grow into the success story that today is food manufacturer Cacique.|
|Sex offender registry questioned after New Hampshire prep school grad convicted of sex crimes|
|A New Hampshire prep school graduate convicted of having sexual contact with a 15-year-old classmate as part of a game of sexual conquest must register as a sex offender for life, a punishment his lawyer likens to being branded.|
|4 Ways to Overcome Your Unreasonable Fears|
|Your fear of running across a busy highway is good. If you're afraid to seize an opportunity, that's a problem.|
|6 Keys to Employee Engagement During Times of Distraction|
|During times of economic slowdown, which includes the summer months, what you can do to keep your employee morale high and performance at its peak?|
|Jury gets case after white supremacist vows to 'die a martyr' for Kansas Jewish site killings|
|The man who admitted killing three people at two suburban Kansas City Jewish sites told jurors Monday that he hoped to "die a martyr" for the shootings, which he said were motivated by "the genocide against white people by Jews." The jury of seven men and five women began deliberating Monday afternoon, shortly after hearing the rambling closing argument by Frazier Glenn Miller, 74, of Aurora, Missouri, who is representing himself at trial.|
|US Supreme Court says ex-Virginia governor can stay out of prison while he appeals convictions|
|Former Virginia Gov. Bob McDonnell will not have to go to prison while the U.S. Supreme Court considers whether to consider his appeal of his public corruption convictions.|
|Skewed view: UNC's ‘Literature of 9/11’ course blames America, say critics|
|A University of North Carolina English course on the 9/11 attacks comes with a lengthy reading list of works that critics say portray Americans as the bad guys and radical Islamists as sympathetic, but some of the professor's former students warn those taking the class not to disagree with the professor.|
|Former Subway spokesman Fogle suing one-time friend/employee over home loan default|
|Former Subway pitchman Jared Fogle is suing the incarcerated former head of his charitable foundation for allegedly defaulting on a $191,000 personal loan to buy an Indianapolis home.|